Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: A case-control study

Annals of the Rheumatic Diseases

Volumn 71, Issue 1, 2012, Pages 61-66

  Martinez Zamora, Maria Angeles ^a   Peralta, Sara ^a   Creus, Montserrat ^a   Tassies, Dolors ^a   Reverter, Juan Carlos ^a   Espinosa, Gerard ^a   Cervera, Ricard ^a   Carmona, Francisco ^a   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SPONTANEOUS ABORTION; THROMBOEMBOLISM; THROMBOSIS;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PROGNOSIS; RISK; THROMBOEMBOLISM; YOUNG ADULT;

EID: 82955214541     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.153817     Document Type: Article

References (34)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11. (Pubitemid 30265586)
2. Empson M, Lassere M, Craig JC, et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99:135-44. (Pubitemid 34075480)
3. Rai R. Is miscarriage a coagulopathy? Curr Opin Obstet Gynecol 2003;15:265-8. (Pubitemid 36677335)
4. Khamashta MA. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies. J Autoimmun 2000;15:249-53.
5. Meroni PL. Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 2008;30:99-103.
6. Meroni PL, Shoenfeld Y. Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies. Autoimmun Rev 2008;7:585-7.
7. Shoenfeld Y, Meroni PL, Cervera R. Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 2008;67:438-42. (Pubitemid 351498420)
8. Erkan D, Merrill JT, Yazici Y, et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001;44:1466-7. (Pubitemid 32537548)
9. Tincani A, Taglietti M, Biasini C, et al. Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al. Arthritis Rheum 2002;46:1126-7;author reply 1127.
10. Quenby S, Farquharson RG, Dawood F, et al. Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod 2005;20:1729-32. (Pubitemid 40852272)
11. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
12. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
13. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993;90:1004-8. (Pubitemid 23053939)
14. Fábregues F, Tàssies D, Reverter JC, et al. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004;81:989-95. (Pubitemid 38452963)
15. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3 -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703. (Pubitemid 26383091)
16. Abildgaard U, Lie M, Odegård OR. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res 1977;11:549-53. (Pubitemid 8340427)
17. Bertina RM, Broekmans AW, Krommenhoek-van Es C, et al. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost 1984;51:1-5. (Pubitemid 14159187)
18. Amiral J, Grosley B, Boyer-Neumann C, et al. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form. Blood Coagul Fibrinolysis 1994;5:179-86. (Pubitemid 24138050)
19. Lewis MA. The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect. Hum Reprod Update 1999;5:707-20. (Pubitemid 30034893)
20. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921.
21. Schane RE, Ling PM, Glantz SA. Health effects of light and intermittent smoking: a review. Circulation 2010;121:1518-22.
22. Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009;8:998-1005.
23. Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009;68:1428-32.
24. Schlesselman J, Stolley P. Case-control studies. Design, conduct, analysis . New York, NY: Oxford University Press, 1982.
25. G insburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997-1002.
26. Simioni P, Tormene D, Spiezia L, et al. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost 2006;32:700-8. (Pubitemid 44623377)
27. Galli M, Luciani D, Bertolini G, et al. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003;102:2717-23. (Pubitemid 37248837)
28. Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 2011;70:1083-6.
29. Martínez-Zamora MA, Creus M, Tassies D, et al. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome. Fertil Steril 2010;94:2437-40.
30. Smith GC, Pell JP, Walsh D. Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study. BMJ 2003;326:423-4. (Pubitemid 36246313)
31. Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 2007;56:2382-91. (Pubitemid 47173586)
32. Danowski A, de Azevedo MN, de Souza Papi JA, et al. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 2009;36:1195-9.
33. Hereng T, Lambert M, Hachulla E, et al. Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus 2008;17:11-15. (Pubitemid 351487013)
34. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6. (Pubitemid 32592386)